D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine

D-amino acid oxidase (DAO, DAAO) degrades the NMDA receptor co-agonist D-serine, modulating D-serine levels and thence NMDA receptor function. DAO inhibitors are under development as a therapy for schizophrenia, a disorder involving both NMDA receptor and dopaminergic dysfunction. However, a direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Betts, Jill F., Schweimer, Judith V., Burnham, Katherine E., Burnet, Philip W. J., Sharp, Trevor, Harrison, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014674/
https://www.ncbi.nlm.nih.gov/pubmed/24822045
http://dx.doi.org/10.3389/fnsyn.2014.00011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014674/
https://www.ncbi.nlm.nih.gov/pubmed/24822045
http://dx.doi.org/10.3389/fnsyn.2014.00011

Ejemplares similares